Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment
Skinvisible Pharmaceuticals files a provisional patent for transdermal obesity drug delivery using Invisicare technology. This needle-free, topical solution enhances drug absorption and patient compliance, revolutionizing obesity treatment. Skinvisible seeks partners to bring this innovation to market.
